TBL1XR1 and gastric cancer: According to the subgroup analysis for OS, TBL1XR1 might be served as a promising biomarker for GC (HR: 1.74, 95 % CI: 1.43–2.05; p < 0.001) and acted as an independent prognostic factor (HR: 1.73, 95 % CI: 1.44–2.03, p < 0.001).